Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$533M |
| 2 |
Apple
AAPL
|
+$347M |
| 3 |
Micron Technology
MU
|
+$272M |
| 4 |
Eli Lilly
LLY
|
+$232M |
| 5 |
Super Micro Computer
SMCI
|
+$185M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$472M |
| 2 |
NVIDIA
NVDA
|
+$413M |
| 3 |
Tesla
TSLA
|
+$403M |
| 4 |
Coinbase
COIN
|
+$236M |
| 5 |
Johnson & Johnson
JNJ
|
+$224M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.66% |
| 2 | Healthcare | 16.81% |
| 3 | Consumer Discretionary | 13.04% |
| 4 | Industrials | 9.62% |
| 5 | Financials | 9.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Palantir
PLTR
$420B
| $1.43B | 2.15% |
38,419,240
-1,096,069
| -3% | -$33.6M |
|
|
NVO
2
Novo Nordisk
NVO
$207B
| $975M | 1.47% |
8,189,315
-976,059
| -11% | -$130M |
|
3
United Therapeutics
UTHR
$22.1B
| $772M | 1.16% |
2,155,392
-19,300
| -0.9% | -$6.52M |
|
|
4
Apple
AAPL
$4.45T
| $763M | 1.15% |
3,276,203
+1,554,759
| +90% | +$347M |
|
5
Vertex Pharmaceuticals
VRTX
$134B
| $759M | 1.14% |
1,631,493
+65,105
| +4% | +$31.3M |
|
|
6
Microsoft
MSFT
$3.74T
| $676M | 1.02% |
1,571,271
+1,246,346
| +384% | +$533M |
|
7
VeriSign
VRSN
$26B
| $603M | 0.91% |
3,175,990
+148,294
| +5% | +$26.7M |
|
8
Sprouts Farmers Market
SFM
$7.87B
| $490M | 0.74% |
4,440,644
+2,500
| +0.1% | +$238K |
|
9
Airbnb
ABNB
$111B
| $459M | 0.69% |
3,616,495
+215,090
| +6% | +$27.9M |
|
|
10
NVIDIA
NVDA
$5.27T
| $428M | 0.64% |
3,528,071
-3,493,719
| -50% | -$413M |
|
11
Exelixis
EXEL
$12.7B
| $399M | 0.6% |
15,359,916
+196,850
| +1% | +$4.89M |
|
12
Franco-Nevada
FNV
$46.4B
| $390M | 0.59% |
3,138,549
+64,600
| +2% | +$8M |
|
13
Cboe Global Markets
CBOE
$29.5B
| $385M | 0.58% |
1,879,724
+5,000
| +0.3% | +$982K |
|
14
Fortinet
FTNT
$119B
| $383M | 0.58% |
4,943,162
-83,232
| -2% | -$5.69M |
|
15
Meta Platforms (Facebook)
META
$1.53T
| $371M | 0.56% |
647,424
-398,709
| -38% | -$205M |
|
16
Gilead Sciences
GILD
$168B
| $351M | 0.53% |
4,188,524
-869,074
| -17% | -$66.3M |
|
17
Allison Transmission
ALSN
$10.3B
| $329M | 0.49% |
3,423,419
-99,100
| -3% | -$8.5M |
|
18
monday.com
MNDY
$3.7B
| $316M | 0.48% |
1,138,290
+15,600
| +1% | +$3.86M |
|
19
DoorDash
DASH
$91.9B
| $312M | 0.47% |
2,186,688
-601,155
| -22% | -$72.9M |
|
20
CME Group
CME
$93.2B
| $310M | 0.47% |
1,403,089
+784,500
| +127% | +$162M |
|
21
Corcept Therapeutics
CORT
$12.1B
| $301M | 0.45% |
6,509,002
-403,569
| -6% | -$14.3M |
|
22
Netflix
NFLX
$311B
| $298M | 0.45% |
4,202,090
+1,485,090
| +55% | +$99.3M |
|
23
Incyte
INCY
$24.5B
| $297M | 0.45% |
4,499,540
-718,797
| -14% | -$45.8M |
|
24
Neurocrine Biosciences
NBIX
$16.5B
| $297M | 0.45% |
2,574,546
+106,400
| +4% | +$14.6M |
|
25
Wingstop
WING
$3.03B
| $291M | 0.44% |
699,146
+96,156
| +16% | +$37.4M |
|
Similar funds
Jim Simons's Q3 2024 Portfolio in Review
As of Q3 2024, Jim Simons held 4,024 positions worth $66.5B, up 13% from $59B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons deployed $3.2B of net new capital in Q3 2024, opening 578 new positions and adding to 1,558 existing holdings. Its largest new stake was Micron Technology: 2,604,914 shares worth $270M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was NVIDIA, an estimated $413M trimmed.
- Jim Simons's largest Q3 2024 buy was Micron Technology: 2,604,914 shares worth $270M.
- Jim Simons added most to Microsoft in Q3 2024, an estimated $533M increase.
- Jim Simons's biggest Q3 2024 reduction was NVIDIA, cutting an estimated $413M.
- Jim Simons fully exited Broadcom in Q3 2024, selling an estimated $472M.
- Jim Simons's ten largest holdings make up 11% of its $66.5B portfolio in Q3 2024.
- Jim Simons opened 578 new positions and closed 539 in Q3 2024.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $66.5B.
Based on Renaissance Technologies's 13F filing for Q3 2024, filed 13 Nov 2024.